Citation Impact
Citing Papers
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
The Molecular Basis of Pluripotency in Mouse Embryonic Stem Cells
2004
Interleukin-6 (IL-6) and/or Soluble IL-6 Receptor Down-regulation of Human Type II Collagen Gene Expression in Articular Chondrocytes Requires a Decrease of Sp1·Sp3 Ratio and of the Binding Activity of Both Factors to the COL2A1 Promoter
2007
Nanog Is the Gateway to the Pluripotent Ground State
2009 StandoutNobel
Inactivation of IL11 Signaling Causes Craniosynostosis, Delayed Tooth Eruption, and Supernumerary Teeth
2011
Esrrb Is a Direct Nanog Target Gene that Can Substitute for Nanog Function in Pluripotent Cells
2012
GP130/OSMR is the only LIF/IL‐6 family receptor complex to promote osteoblast differentiation of calvaria progenitors
2005
In vivo effects of superantigens
1995
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Interleukin‐6: Structure‐function relationships
1997
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors
2006 StandoutNobel
GPL, a Novel Cytokine Receptor Related to GP130 and Leukemia Inhibitory Factor Receptor
2003
Separate Functions for the Two Modules of the Membrane-proximal Cytokine Binding Domain of Glycoprotein 190, the Leukemia Inhibitory Factor Low Affinity Receptor, in Ligand Binding and Receptor Activation
2002
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
2007 StandoutNobel
The bacterial superantigen and superantigen‐like proteins
2008
The ground state of embryonic stem cell self-renewal
2008 StandoutNature
Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin‐6 signal transducer gp1301
1997
Crystal structure of a cytokine-binding region of gp130
1998
The role of reactive oxygen species in homeostasis and degradation of cartilage
2003
Induction of pluripotent stem cells from fibroblast cultures
2007 StandoutNobel
Osteoarthritis
2015 Standout
Understanding the mechanism of action of bacterial superantigens from a decade of research
1999
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Differential Roles for Sox15 and Sox2 in Transcriptional Control in Mouse Embryonic Stem Cells
2005 StandoutNobel
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
2010 Standout
Identifying effector molecules, cells, and cytokines of innate immunity in OA
2020
Superantigens
1994
Visualizing muscle cell migration in situ
2000
Identification of Putative Target Genes of the Transcription Factor RUNX2
2013 StandoutNobel
Avidin as a model for charge driven transport into cartilage and drug delivery for treating early stage post-traumatic osteoarthritis
2013 StandoutNobel
Central nervous system control of food intake
2000 StandoutNature
GP130 cytokines and bone remodelling in health and disease
2010
BMP Induction of Id Proteins Suppresses Differentiation and Sustains Embryonic Stem Cell Self-Renewal in Collaboration with STAT3
2003 Standout
Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells
2003 Standout
Generation of germline-competent induced pluripotent stem cells
2007 StandoutNatureNobel
The IFN-λ-IFN-λR1-IL-10Rβ Complex Reveals Structural Features Underlying Type III IFN Functional Plasticity
2017 StandoutNobel
The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene
1999 Standout
Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells
2005 Standout
STATs in cancer inflammation and immunity: a leading role for STAT3
2009 Standout
A functional role of the membrane‐proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor
2002
MHC Class II-Dependent Peptide Antigen Versus Superantigen Presentation to T Cells
1997
Self-renewal of teratocarcinoma and embryonic stem cells
2004
Solution structure of recombinant human interleukin-6 1 1Edited by P. E. Wright
1997
ECAT11/L1td1 Is Enriched in ESCs and Rapidly Activated During iPSCGeneration, but It Is Dispensable for the Maintenance and Induction of Pluripotency
2011 StandoutNobel
Stem Cells and Cancer
2004 Standout
Siglec-9, a Novel Sialic Acid Binding Member of the Immunoglobulin Superfamily Expressed Broadly on Human Blood Leukocytes
2000
Obesity and the Regulation of Energy Balance
2001 Standout
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
The Immunoglobulin-like Module of gp130 Is Required for Signaling by Interleukin-6, but Not by Leukemia Inhibitory Factor
1998
Convergent Mechanisms for Recognition of Divergent Cytokines by the Shared Signaling Receptor gp130
2003 StandoutNobel
Response of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides
1999
The Jak-STAT signaling pathway is required but not sufficient for the antiviral response of drosophila
2005 StandoutNobel
Superantigens and Their Potential Role in Human Disease
1993
lincRNAs act in the circuitry controlling pluripotency and differentiation
2011 StandoutNature
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
The ciliary neurotrophic factor receptor alpha component induces the secretion of and is required for functional responses to cardiotrophin-like cytokine
2001
NEW EMBO MEMBERS' REVIEW: Receptor recognition by gp130 cytokines
2000
Staphylococcus aureusInfections
1998 Standout
The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells
2003 StandoutNobel
Different epitopes are required for gp130 activation by interleukin‐6, oncostatin M and leukemia inhibitory factor
2000
Mechanical injury potentiates proteoglycan catabolism induced by interleukin‐6 with soluble interleukin‐6 receptor and tumor necrosis factor α in immature bovine and adult human articular cartilage
2009
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction
2011
The immunopathogenesis of sepsis
2002 StandoutNature
Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
2013 Standout
Two Different Epitopes of the Signal Transducer gp130 Sequentially Cooperate on IL-6-Induced Receptor Activation
2000
Importance of the Membrane-Proximal Extracellular Domains for Activation of the Signal Transducer Glycoprotein 130
2000
Cell Migration: Integrating Signals from Front to Back
2003 StandoutScience
Natural Product Synthesis Using Multicomponent Reaction Strategies
2009 Standout
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
2003 Standout
Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer
2000
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Identification of a Leu-Ile internalization motif within the cytoplasmic domain of the leukaemia inhibitory factor receptor
1999
Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance
1997
Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex
2003 Science
Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions
1998
Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins
1993
Brown Adipose Tissue: Function and Physiological Significance
2004 Standout
Reactivation of the Paternal X Chromosome in Early Mouse Embryos
2004 StandoutScienceNobel
Cytokine Storm
2020 Standout
Calcitonin Gene-Related Peptide Decreases Expression of HLA-DR and CD86 by Human Dendritic Cells and Dampens Dendritic Cell-Driven T Cell-Proliferative Responses Via the Type I Calcitonin Gene-Related Peptide Receptor
2000 StandoutNobel
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
1998 Standout
The Mechanism of Superantigen-Mediated Toxic Shock: Not a Simple Th1 Cytokine Storm
2005
Determination of the absolute stereochemistry and asymmetric total synthesis of madindolines A and B: a practical improvement to a second-generation approach from the first-generation
2005 StandoutNobel
Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex
2001 Science
Efficient Total Synthesis of Novel Bioactive Microbial Metabolites
2008 StandoutNobel
Nonproliferating Bystander CD4+ T Cells Lacking Activation Markers Support HIV Replication During Immune Activation
2001 StandoutNobel
Bacterial pyrogenic exotoxins as superantigens
1995
Structural Biology of Shared Cytokine Receptors
2007
Virus and Autoimmunity: Induction of Autoimmune Disease in Mice by Mouse T Lymphotropic Virus (MTLV) Destroying CD4+ T Cells
1999 StandoutNobel
Works of Keith Hudson being referenced
Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown
2001
Interleukin-11 Signals through the Formation of a Hexameric Receptor Complex
2000
T‐Cell Receptor β‐Chain Binding to Enterotoxin Superantigens
1993
Co-localization of Racl and E-Cadherin in Human Epidermal Keratinocytes
2000
Production and characterization of monoclonal antibodies against the leukemia inhibitory factor low affinity receptor, gp190
1997
Superantigens —remnants of a past process?
1993
Enterotoxin residues determining T-cell receptor Vβ binding specificity
1992 Nature
An Antagonist for the Leukemia Inhibitory Factor Receptor Inhibits Leukemia Inhibitory Factor, Cardiotrophin-1, Ciliary Neurotrophic Factor, and Oncostatin M
1997
The interactions of the cytokine-binding homology region and immunoglobulin-like domains of gp130 with oncostatin M: implications for receptor complex formation
1998
Identification of Three Distinct Receptor Binding Sites of Murine Interleukin-11
1999
Characterization of the Receptor Binding Sites of Human Leukemia Inhibitory Factor and Creation of Antagonists
1996
Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II.
1995
Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor V beta specificity.
1993
Receptor recognition by gp130 cytokines
2000
Crystal structure and functional dissection of the cytostatic cytokine oncostatin M
2000
Mediation of interleukin-11-dependent biological responses by a soluble form of the interleukin-11 receptor
1996
Identification of ciliary neurotrophic factor (CNTF) residues essential for leukemia inhibitory factor receptor binding and generation of CNTF receptor antagonists.
1996